Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: Long-term results of a prospective randomized trial

Journal of Clinical Oncology

Volumn 30, Issue 8, 2012, Pages 800-805

  Lorch, Anja ^a   Kleinhans, Antje ^a   Kramar, Andrew ^g   Kollmannsberger, Christian K ^b,h   Hartmann, Jor̈g T ^b,c   Bokemeyer, Carsten ^d   Rick, Oliver ^e   Beyer, Jor̈g ^f  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Klinikum Reinhardshöhe   (Germany)

^f VIVANTES KLINIKUM AM URBAN   (Germany)

^g CENTRE OSCAR LAMBRET   (France)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG MEGADOSE; FOLLOW UP; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE PAYMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROSPECTIVE STUDIES; SEMINOMA; STEM CELL TRANSPLANTATION; TESTICULAR NEOPLASMS;

EID: 84858808659     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.6391     Document Type: Article

References (15)

1. Einhorn LH, Williams SD, Chamness A, et al: High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357:340-348, 2007 (Pubitemid 47124134)
2. Lorch A, Bascoul-Mollevi C, Kramar A, et al: Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database. J Clin Oncol 29:2178-2184, 2011
3. International Prognostic Factors Study Group, Lorch A, Beyer J, et al: Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906-4911, 2010
4. Lorch A, Neubauer A, Hackenthal M, et al: High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. Ann Oncol 21:820-825, 2010
5. Vaena DA, Abonour R, Einhorn LH: Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. J Clin Oncol 21:4100-4104, 2003 (Pubitemid 46606176)
6. Lorch A, Kollmannsberger C, Hartmann, JT, et al: Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: A prospective randomized multicenter trial of the German Testicular Cancer Study Group. J Clin Oncol, 25:2778-2784, 2007 (Pubitemid 47123186)
7. Pico JL, Rosti G, Kramar A, et al: A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16:1152-1159, 2005 (Pubitemid 41418319)
8. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
9. Rick O, Beyer J, Kingreen D, et al: High-dose chemotherapy in germ cell tumours: A large single centre experience. Eur J Cancer 34:1883-1888, 1998 (Pubitemid 28535436)
10. Nichols CR, Andersen J, Lazarus HM, et al: High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group protocol. J Clin Oncol 10:558-563, 1992
11. Hartmann JT, Schmoll HJ, Kuczyk MA, et al: Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. Ann Oncol 8:531-538, 1997
12. Rick O, Bokemeyer C, Weinknecht S, et al: Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. J Clin Oncol 22:3713-3719, 2004 (Pubitemid 41095211)
13. Kollmannsberger C, Mayer F, Kuczyk M, et al: Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy. World J Urol 19:120-125, 2001 (Pubitemid 33777042)
14. Feldman DR, Bosl GJ, Sheinfeld J, et al: Medical treatment of advanced testicular cancer. JAMA 299:672-674, 2008
15. Lorch A, Rick O, Wündisch T, et al: High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors. J Urol 184:168-173, 2010